Claudia Vellozzi1, Shahed Iqbal, Brock Stewart, Jerome Tokars, Frank DeStefano. 1. Claudia Vellozzi, Shahed Iqbal, Brock Stewart, and Frank DeStefano are with the Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Jerome Tokars is with the Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention.
Abstract
OBJECTIVES: We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic. METHODS: We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators. RESULTS: There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS. CONCLUSIONS: Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.
OBJECTIVES: We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic. METHODS: We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators. RESULTS: There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS. CONCLUSIONS: Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.
Authors: David N Juurlink; Therese A Stukel; Jeffrey Kwong; Alexander Kopp; Allison McGeer; Ross E Upshur; Douglas G Manuel; Rahim Moineddin; Kumanan Wilson Journal: Arch Intern Med Date: 2006-11-13
Authors: T Lasky; G J Terracciano; L Magder; C L Koski; M Ballesteros; D Nash; S Clark; P Haber; P D Stolley; L B Schonberger; R T Chen Journal: N Engl J Med Date: 1998-12-17 Impact factor: 91.245
Authors: L B Schonberger; D J Bregman; J Z Sullivan-Bolyai; R A Keenlyside; D W Ziegler; H F Retailliau; D L Eddins; J A Bryan Journal: Am J Epidemiol Date: 1979-08 Impact factor: 4.897
Authors: Clarence C Tam; Sarah J O'Brien; Irene Petersen; Amir Islam; Andrew Hayward; Laura C Rodrigues Journal: PLoS One Date: 2007-04-04 Impact factor: 3.240
Authors: Penina Haber; Pedro L Moro; Paige Lewis; Emily Jane Woo; Christopher Jankosky; Maria Cano Journal: Vaccine Date: 2016-03-23 Impact factor: 3.641
Authors: Kam Lun Hon; Yin Ching K Tsang; Lawrence C N Chan; Daniel K K Ng; Ting Yat Miu; Johnny Y Chan; Albert Lee; Ting Fan Leung Journal: NPJ Prim Care Respir Med Date: 2016-04-07 Impact factor: 2.871
Authors: Ji Hyen Hwang; Chang Hoon Lim; Dong Ho Kim; Byung Wook Eun; Dae Sun Jo; Young Hwan Song; Yun Kyung Kim Journal: J Korean Med Sci Date: 2017-02 Impact factor: 2.153